Beam Therapeutics

In News

Two Programs That Could Make or Break Beam Therapeutics Inc (BEAM) Stock - Yahoo Finance

Yahoo Finance - May 20, 2026

A Look At Beam Therapeutics (BEAM) Valuation After Updated BEAM 302 Trial Data And Accelerated Approval Plans - simplywall.st

simplywall.st - May 30, 2026

Beam Therapeutics: 2026 TIME100 Most Influential Companies - Time Magazine

Time Magazine - Apr 30, 2026

BEAM Stock Price, Quote & Chart | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill

ChartMill - May 29, 2026

Beam Therapeutics Presents Recently Reported Topline - GlobeNewswire

GlobeNewswire - May 18, 2026

Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street - Sixth Street

Sixth Street - Feb 24, 2026

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? - The Motley Fool

The Motley Fool - May 26, 2026

Beam Therapeutics eyes sickle cell BLA as Alpha-1 gene-editing program advances - MSN

MSN - May 30, 2026

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? - Yahoo Finance

Yahoo Finance - May 26, 2026

Why Beam Therapeutics (BEAM) Is Up 13.1% After Pursuing Accelerated Approval For BEAM-302 - simplywall.st

simplywall.st - May 27, 2026

Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference - GlobeNewswire

GlobeNewswire - May 13, 2026

Beam Therapeutics (BEAM) Is Up 17.6% After Advancing BEAM-302 Toward Accelerated Approval in AATD - Yahoo Finance

Yahoo Finance - May 28, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment